|
CARMENA: Cytoreductive nephrectomy followed by sunitinib versus sunitinib alone in metastatic renal cell carcinoma—Results of a phase III noninferiority trial. |
|
|
Honoraria - Ipsen; Novartis; Pfizer |
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Sanofi |
Research Funding - Pfizer (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Novartis; Roche |
|
|
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Novartis; Pfizer; Roche/Genentech |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EUSA Pharma; Exelixis; Ipsen; Novartis; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Ipsen; Janssen; Pfizer |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Novartis |
|
|
Consulting or Advisory Role - Intuitive Surgical; Novartis; Pfizer |
Travel, Accommodations, Expenses - Ipsen; Pfizer |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Astellas Oncology; Ipsen; Janssen; Sanofi |
|
|
Honoraria - Ipsen; Janssen; Takeda |
Travel, Accommodations, Expenses - Intuitive Surgical; Ipsen; Pierre Fabre |
|
|
Honoraria - AstraZeneca; Pfizer |
Consulting or Advisory Role - Novartis; Pfizer |
Speakers' Bureau - Bristol-Myers Squibb |
Research Funding - Janssen (Inst); Merck (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Ipsen |
|
|
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; NOVARTIS; SANOFI; Takeda |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer |
|
|
Consulting or Advisory Role - Ipsen; Novartis; Pfizer; Sanofi |
Travel, Accommodations, Expenses - Ipsen; Pfizer |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck (Inst); Novartis; Novartis (Inst); Pfizer (Inst); Roche (Inst) |
|
|
|
Travel, Accommodations, Expenses - Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Novartis; Pfizer |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb |
|
|
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer |
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche |
Research Funding - Novartis (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer |